KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 142 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $232,000 | +14.9% | 39,646 | +4.2% | 0.01% | +50.0% |
| Q3 2016 | $202,000 | -78.6% | 38,043 | -73.3% | 0.00% | -75.0% |
| Q2 2016 | $943,000 | +28.6% | 142,343 | -9.3% | 0.02% | +23.1% |
| Q1 2016 | $733,000 | +218.7% | 157,022 | +245.1% | 0.01% | +550.0% |
| Q4 2015 | $230,000 | -53.2% | 45,500 | -7.4% | 0.00% | -60.0% |
| Q2 2015 | $491,000 | +206.9% | 49,142 | +322.1% | 0.01% | +400.0% |
| Q3 2014 | $160,000 | -86.9% | 11,643 | -85.4% | 0.00% | -83.3% |
| Q2 2014 | $1,224,000 | -53.0% | 79,579 | -48.0% | 0.01% | -57.1% |
| Q1 2014 | $2,606,000 | -45.5% | 152,940 | -58.6% | 0.01% | -44.0% |
| Q4 2013 | $4,783,000 | +66.1% | 369,388 | +29.4% | 0.02% | +38.9% |
| Q3 2013 | $2,879,000 | -49.0% | 285,424 | -62.2% | 0.02% | -47.1% |
| Q2 2013 | $5,647,000 | – | 755,979 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,312,006 | $22,357,000 | 15.70% |
| VHCP Management, LLC | 1,000,273 | $17,045,000 | 8.86% |
| HARVEY CAPITAL MANAGEMENT INC | 915,800 | $15,605,000 | 6.22% |
| Baupost Group | 6,310,850 | $107,537,000 | 2.60% |
| SECTORAL ASSET MANAGEMENT INC | 3,537,590 | $60,281,000 | 2.48% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 587,504 | $10,011,000 | 2.31% |
| Knoll Capital Management, LLC | 200,000 | $3,408,000 | 1.76% |
| Camber Capital Management LP | 1,250,000 | $21,300,000 | 1.67% |
| NORTHPOINTE CAPITAL LLC | 877,875 | $14,958,000 | 1.52% |
| DAFNA Capital Management LLC | 100,000 | $1,704,000 | 1.46% |